Version 5.4
Homo sapiens Protein: ELFN1
Summary
InnateDB Protein IDBP-718117.3
Last Modified 2014-10-13 [Report errors or provide feedback]
Gene Symbol ELFN1
Protein Name
Synonyms
Species Homo sapiens
Ensembl Protein ENSP00000456548
InnateDB Gene IDBG-297120 (ELFN1)
Protein Structure
UniProt Annotation
Function
Subcellular Localization
Disease Associations
Tissue Specificity
Comments
Interactions
Number of Interactions This gene and/or its encoded proteins are associated with 1 experimentally validated interaction(s) in this database.
Experimentally validated
Total 1 [view]
Protein-Protein 1 [view]
Protein-DNA 0
Protein-RNA 0
DNA-DNA 0
RNA-RNA 0
DNA-RNA 0
Gene Ontology

Molecular Function
Accession GO Term
GO:0004864 protein phosphatase inhibitor activity
GO:0005515 protein binding
GO:0019902 phosphatase binding
Biological Process
GO:0010923 negative regulation of phosphatase activity
GO:0050808 synapse organization
Cellular Component
GO:0016021 integral component of membrane
GO:0030425 dendrite
GO:0060076 excitatory synapse
GO:0070062 extracellular vesicular exosome
Protein Structure and Domains
PDB ID
InterPro IPR000483 Cysteine-rich flanking region, C-terminal
IPR003591 Leucine-rich repeat, typical subtype
IPR003961 Fibronectin, type III
PFAM PF01463
PF00041
PF01108
PRINTS
PIRSF
SMART SM00082
SM00369
SM00060
TIGRFAMs
Post-translational Modifications
Modification
Cross-References
SwissProt P0C7U0
PhosphoSite PhosphoSite-P0C7U0
TrEMBL
UniProt Splice Variant
Entrez Gene 392617
UniGene Hs.719712
RefSeq XP_006715788
HUGO HGNC:33154
OMIM 614964
CCDS CCDS59046
HPRD
IMGT
EMBL AC074389
GenPept

If you use InnateDB for your research, please cite the following publication:

Breuer et al., InnateDB: systems biology of innate immunity and beyond - recent updates and continuing curation. Nucl. Acids Res. (2013) 41 (D1) 

InnateDB is being developed jointly by the Brinkman Laboratory (Simon Fraser University, British Columbia, Canada), the Hancock Laboratory (University of British Columbia, Vancouver, British Columbia) and the Lynn EMBL Australia Group (South Australian Health & Medical Research Institute and Flinders University, Adelaide, Australia).

Funding is currently provided by Allergen and EMBL Australia. Previous funding has been provided by Genome Canada, the Foundation for the National Institutes of Health through the Grand Challenges in Global Health initiative and by Teagasc. InnateDB curated interactions are licensed under the Design Science License. All other data is licensed under the terms of the originating database. Contact: innatedb-mail@sfu.ca